{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:32:25Z","timestamp":1791995545787,"version":"4.4.0"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.bone.2026.117892","type":"journal-article","created":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T17:03:12Z","timestamp":1775667792000},"page":"117892","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["The effect of prior osteoporosis treatment on bone mineral density response to romosozumab"],"prefix":"10.1016","volume":"209","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-0816-7093","authenticated-orcid":false,"given":"Brenda","family":"Ta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flora Cheuk Wah","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9682-2313","authenticated-orcid":false,"given":"Dana","family":"Bliuc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4940-7445","authenticated-orcid":false,"given":"Weiwen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5278-4527","authenticated-orcid":false,"given":"Jacqueline R.","family":"Center","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2599-8503","authenticated-orcid":false,"given":"Angela","family":"Sheu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2026.117892_bb0005","series-title":"A Burden of Disease Analysis 2023\u20132033","article-title":"Osteoporosis and fractures in Australia","author":"Mudiyanselage","year":"2024"},{"issue":"16","key":"10.1016\/j.bone.2026.117892_bb0010","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa1607948","article-title":"Romosozumab treatment in postmenopausal women with osteoporosis","volume":"375","author":"Cosman","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.bone.2026.117892_bb0015","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1056\/NEJMoa1305224","article-title":"Romosozumab in postmenopausal women with low bone mineral density","volume":"370","author":"McClung","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"15","key":"10.1016\/j.bone.2026.117892_bb0020","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1056\/NEJMoa1708322","article-title":"Romosozumab or alendronate for fracture prevention in women with osteoporosis","volume":"377","author":"Saag","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.bone.2026.117892_bb0025","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1111\/imj.16317","article-title":"Australian clinicians\u2019 perceptions of patients with very high risk of fracture","volume":"54","author":"Girgis","year":"2024","journal-title":"Intern. Med. J."},{"issue":"11","key":"10.1016\/j.bone.2026.117892_bb0030","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1007\/s00198-022-06545-1","article-title":"Impact of the duration of previous osteoporosis treatment on the effect of romosozumab in patients with postmenopausal osteoporosis","volume":"33","author":"Ebina","year":"2022","journal-title":"Osteoporos. Int."},{"issue":"7","key":"10.1016\/j.bone.2026.117892_bb0035","doi-asserted-by":"crossref","DOI":"10.1002\/jbm4.10512","article-title":"Skeletal responses to romosozumab after 12 months of denosumab","volume":"5","author":"McClung","year":"2021","journal-title":"JBMR Plus"},{"issue":"6","key":"10.1016\/j.bone.2026.117892_bb0040","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1007\/s00198-021-06261-2","article-title":"Effect of the duration of previous osteoporosis treatment on the effect of romosozumab treatment","volume":"33","author":"Tominaga","year":"2022","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2026.117892_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2020.115574","article-title":"Effects of prior osteoporosis treatment on early treatment response of romosozumab in patients with postmenopausal osteoporosis","volume":"140","author":"Ebina","year":"2020","journal-title":"Bone"},{"key":"10.1016\/j.bone.2026.117892_bb0055","doi-asserted-by":"crossref","DOI":"10.1093\/jbmr\/zjaf037","article-title":"Denosumab discontinuation in the clinic: implications of rebound bone turnover and emerging strategies to prevent bone loss and fractures","author":"Kumar","year":"2025","journal-title":"J. Bone Miner. Res."},{"issue":"9","key":"10.1016\/j.bone.2026.117892_bb0060","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1007\/s00198-024-07139-9","article-title":"A novel sequential treatment approach between denosumab and romosozumab in patients with severe osteoporosis","volume":"35","author":"Kumar","year":"2024","journal-title":"Osteoporos. Int."},{"issue":"11","key":"10.1016\/j.bone.2026.117892_bb0065","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1007\/s00198-022-06545-1","article-title":"Impact of the duration of previous osteoporosis treatment on the effect of romosozumab in patients with postmenopausal osteoporosis","volume":"33","author":"Ebina","year":"2022","journal-title":"Osteoporos. Int."},{"issue":"9","key":"10.1016\/j.bone.2026.117892_bb0070","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1007\/s00198-024-07155-9","article-title":"The effect of romosozumab on bone mineral density depending on prior treatment: a prospective, multicentre cohort study in Switzerland","volume":"35","author":"Everts-Graber","year":"2024","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2026.117892_bb0075","article-title":"Romosozumab was not effective in preventing multiple spontaneous clinical vertebral fractures after denosumab discontinuation: a case report","volume":"13","author":"Kashii","year":"2020","journal-title":"Bone Rep."},{"key":"10.1016\/j.bone.2026.117892_bb0080","article-title":"Romosozumab and denosumab combination therapy after denosumab in postmenopausal osteoporosis","author":"Adami","year":"2025","journal-title":"Arthritis Rheumatol."},{"issue":"4","key":"10.1016\/j.bone.2026.117892_bb0085","doi-asserted-by":"crossref","DOI":"10.1093\/jbmrpl\/ziae016","article-title":"Romosozumab added to ongoing denosumab in postmenopausal osteoporosis, a prospective observational study","volume":"8","author":"Adami","year":"2024","journal-title":"JBMR Plus"},{"issue":"5","key":"10.1016\/j.bone.2026.117892_bb0090","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1007\/s40618-025-02542-3","article-title":"Early administration of romosozumab prevents rebound of bone resorption related to denosumab withdrawal in fractured post-menopausal women: a real-world prospective study","volume":"48","author":"Piasentier","year":"2025","journal-title":"J. Endocrinol. Invest."},{"issue":"6","key":"10.1016\/j.bone.2026.117892_bb0095","doi-asserted-by":"crossref","first-page":"946","DOI":"10.3803\/EnM.2024.2047","article-title":"Association of delayed denosumab dosing with increased risk of fractures: a population-based retrospective study","volume":"39","author":"Kim","year":"2024","journal-title":"Endocrinol. Metab."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328226001183?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328226001183?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T03:35:08Z","timestamp":1779248108000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328226001183"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":18,"alternative-id":["S8756328226001183"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2026.117892","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of prior osteoporosis treatment on bone mineral density response to romosozumab","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2026.117892","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117892"}}